Replies to post #245785 on Innovation Pharmaceuticals Inc (IPIX)

[BooDog]

That would certainly make sense. Maybe they have worked out the kinks between IPIX and the prurisol CRO and are in the process of analyzing top line data as I type.

And maybe we'll see BTD for brilacidin this week as well.

Oh, and the partnership.

$IPIX

[scottsmith]

Yep you nailed it. Can’t imagine any decent cro would want to work with ipix. Word gets around about deadbeats that violate contracts and don’t pay their bills.

[frrol]

[frrol]

Good to see as always that our little biotech is still operating, making necessary plans for the future. The background on industry and clinical interest in Kevetrin is helpful, and I suspect more truth than hype. Management's credibility is thin, though, in the eyes of the market.

This confirms what we thought: a BP told them K needs to be a pill. We know K is bio-available through the GI, so if the toxicology profile is good, this BP might be interested. They'll have to accept those 2-patient p53 modulation results, or wait while we re-do it with the pill (and on our dime). As long as our capital gets cheaper soon, doesn't matter if we do it on our dime.... Just get K moving again.

So: good to see.

[JTORENCE]

Matagordaville you beat me to the punch with your post. Where the hell is the PR announcing they used part of the 10 million funding to pay off the CRO. Totally fu-ked up.Again leads to suspicion that the "P" results aren't what they thought it to be.